The IL-17 pathway mediated by m6A-modified lncRNA H19: a new mechanism for Jianpi Qingre Tongluo Prescription in repressing inflammation and improving lipid metabolism in gout arthritis

Abstract Background Jianpi Qingre Tongluo Prescription [also named Huangqin Qingrechubi Capsule (HQC)] is an empirical prescription for the treatment of gouty arthritis (GA) with excellent clinical efficacy. Mechanistically, HQC suppresses inflammation and lipid metabolism imbalance in GA by regulat...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Xianheng Zhang, Jian Liu, Xiaolu Chen, Xiang Ding, Shengfeng Liu, Xueni Cheng, Dahai Fang
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2026-03-01
Rangatū:	Chinese Medicine
Ngā marau:	Gouty arthritis Jianpi Qingre Tongluo Prescription Inflammation Lipid metabolism N6-methyladenosine modification LncRNA H19
Urunga tuihono:	https://doi.org/10.1186/s13020-026-01379-z
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!